Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. The Company has two divisions: Pharmaceuticals and Diagnostics. Pharmaceuticals are divided into two sub-divisions: Roche Pharmaceuticals and Chugai. It operates in the United States, Western Europe, Japan, CEMAI (Central and Eastern Europe, Middle East, Africa, Central Asia, Indian Subcontinent), Latin America, Asia-Pacific and Other regions. Diagnostics include five business areas: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. It operates in five geographical regions: Europe, Middle East and Africa (EMEA); North America; Asia-Pacific; Latin America, and Japan.
Basel, Switzerland 4070
|Chairman of the Corporate Executive Committee, Chief Executive Officer||Severin Schwan|
|Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer||Alan Hippe|
|Member of the Enlarged Corporate Executive Committee, Head Roche Pharma Research & Early Development||Mike Burgess|
|Member of the Enlarged Corporate Executive Committee, Head Group Communications||Stephan Feldhaus|
|Member of the Enlarged Corporate Executive Committee, Head of Roche Partnering||Sophie Kornowski-Bonnet|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
|Shares Out.||3.5B||Book Value||$4.53|
|Annual Dividend Rate||$1.69||Price/Sales (TTM)||4.4|
|Ex-Div Date||3/7/13||P/Cash Flow (TTM)||16.4x|
|Pay Date||1/1/01||Operating Margin||30.99%|
*GAAP = prior to non-GAAP analyst adjusted earnings.